Class of 2026
For paramount advancements in cyclin-dependent kinase biology, revealing the mechanisms of CDK activation, the cyclin-CDK-E2F signaling pathway mechanisms responsible for S-phase entry, and the proteasomal pathways governing cell-cycle progression that now underpin several targeted cancer therapies.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]